EUVIMEDEUVIMED entdecken
Crossref

Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide

MD Richard Vaca,, MD Marissa Contento,, MD Edward Wolin,, MD, PhD Emily Gallagher,, MD Virginia Corbett,

Endocrine Abstracts · 04.03.2026

DOI: 10.1530/endoabs.116.o6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von MD Richard Vaca, und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaca,, M. R., Contento,, M. M., Wolin,, M. E., MD, Gallagher,, P. E., & Corbett,, M. V. (2026). Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.o6

Vancouver

Vaca, MR, Contento, MM, Wolin, ME, MD, Gallagher, PE, Corbett, MV. Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.o6

BibTeX
@article{Vaca2026,
  author = {Vaca,, MD Richard and Contento,, MD Marissa and Wolin,, MD Edward and MD and Gallagher,, PhD Emily and Corbett,, MD Virginia},
  title = {Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide},
  journal = {Endocrine Abstracts},
  year = {2026},
  doi = {10.1530/endoabs.116.o6}
}
Kostenlos starten →